SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583648-20-000026
Filing Date
2020-05-11
Accepted
2020-05-11 16:39:51
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pirs3-31x202010xq.htm   iXBRL 10-Q 1093229
2 EXHIBIT 31.1 pirs3-31x20ex311.htm EX-31.1 9926
3 EXHIBIT 31.2 pirs3-31x20ex312.htm EX-31.2 9785
4 EXHIBIT 32.1 pirs3-31x20ex321.htm EX-32.1 5816
5 EXHIBIT 32.2 pirs3-31x20ex322.htm EX-32.2 5737
  Complete submission text file 0001583648-20-000026.txt   5036617

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20200331.xsd EX-101.SCH 35870
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pirs-20200331_cal.xml EX-101.CAL 54701
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pirs-20200331_def.xml EX-101.DEF 175639
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20200331_lab.xml EX-101.LAB 475821
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20200331_pre.xml EX-101.PRE 270208
17 EXTRACTED XBRL INSTANCE DOCUMENT pirs3-31x202010xq_htm.xml XML 778680
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 20865512
SIC: 8731 Services-Commercial Physical & Biological Research